Visual Impairment in Patients with Vernal Keratoconjunctivitis

Authors

  • Awais Ahmad Khan Department of Ophthalmology, Ayub Teaching Hospital Abbottabad, Pakistan
  • Zulfiqar Ali Department of Ophthalmology, Ayub Teaching Hospital Abbottabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i6.2042

Keywords:

Vernal keratoconjunctivitis, visual impairment, corneal complications, allergic eye disease

Abstract

Vernal Keratoconjunctivitis (VKC) is a chronic, recurrent allergic disorder of the ocular surface that predominantly affects children and young adults in warm climates. The disease can lead to corneal complications and permanent visual impairment if inadequately managed. Despite its clinical importance, there is limited data from Pakistan regarding the magnitude and determinants of VKC-associated vision loss. Objective: To determine the frequency and pattern of visual impairment among patients diagnosed with VKC and to assess its association with demographic and clinical factors in a tertiary care hospital of Pakistan. Methods: This descriptive cross-sectional study was conducted at the Department of Ophthalmology, Ayub Teaching Hospital, Abbottabad, from December 2024 to April 2025. A total of 110 clinically diagnosed VKC patients aged 5–50 years were enrolled using a non-probability consecutive sampling technique. Visual acuity was measured using Snellen's chart and classified according to WHO criteria. Detailed ocular examinations were performed to identify corneal complications, including punctate epithelial erosions, shield ulcers, scarring, and keratoconus. Data were analyzed using SPSS version 20, applying Chi-square and Fisher's exact tests; p-values <0.05 were considered statistically significant. Results: The mean age of participants was 15.6 ± 5.8 years, with a male predominance (70%). Most patients were students (73.6%) and resided in urban areas (59.1%). The most common symptoms were itching (100%), redness (94.5%), and foreign body sensation (80.9%). Mixed-type VKC was the most prevalent subtype (51.8%), followed by palpebral (28.2%) and limbal (20.0%). Corneal involvement was observed in 39.1% of patients, with punctate epithelial erosions (20.0%) being the most frequent complication. Visual impairment was present in 36 (32.7%) patients—mild in 16.4%, moderate in 12.7%, and severe in 3.6%. Visual impairment was significantly associated with corneal complications (p = 0.003), male gender (p = 0.021), and low socioeconomic status (p = 0.045). Conclusion: Nearly one-third of VKC patients exhibited visual impairment, predominantly males and those from lower socioeconomic groups. Corneal involvement, particularly erosions and shield ulcers, was the primary determinant of reduced vision. Early recognition and prompt management of VKC, along with public awareness and regular ophthalmic follow-up, are crucial to prevent irreversible visual disability among affected children in Pakistan.

Downloads

Download data is not yet available.

References

Nche E., Okwen M., & Solomon A. Prevalence and clinical characteristics of vernal keratoconjunctivitis in sub-Saharan Africa. Current Opinion in Allergy and Clinical Immunology 2023;23(5):423-429. https://doi.org/10.1097/aci.0000000000000928

Mehta J., Chen W., Cheng A., Cung L., Dualan I., Kekunnaya R.et al.. Diagnosis, management, and treatment of vernal keratoconjunctivitis in Asia: recommendations from the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group. Frontiers in Medicine 2022;9. https://doi.org/10.3389/fmed.2022.882240

Leonardi A., Doan S., Amrane M., Ismail D., Montero J., Németh J.et al.. A randomized, controlled trial of cyclosporine a cationic emulsion in pediatric vernal keratoconjunctivitis. Ophthalmology 2019;126(5):671-681. https://doi.org/10.1016/j.ophtha.2018.12.027

Khalil F., Nilmarani R., Rohaya S., & Novita D. Case report:Diagnosis and treatment of vernal keratoconjunctivitis. JurnalKedokteranDiponegoro (Diponegoro Medical Journal) 2023;12(4):233-237. https://doi.org/10.14710/dmj.v12i4.38080

Gazit I., Wussuki-Lior O., Tauber T., & Morad Y.. Systemic treatment with cyclosporine A in children with severe vernal keratoconjunctivitis. Cornea 2024;44(3):282-285. https://doi.org/10.1097/ico.0000000000003613

Ibraheim K. and Ahmed H. Vernal keratoconjunctivitis in Sudan and its impact on visual acuity. European Journal of Health Sciences 2024;10(3):44-63. https://doi.org/10.47672/ejhs.2025

Minhas S., Tuli R., Sharma G., & Mahajan V. Clinical profile of patients with vernal keratoconjunctivitis. International Journal of Medical and Biomedical Studies 2019;3(8). https://doi.org/10.32553/ijmbs.v3i8.464

Ghauri A., Fisher K., & Kenworthy A. Understanding the journey of patients with vernal keratoconjunctivitis: a qualitative study of the impact on children and families. Journal of Pediatric Ophthalmology & Strabismus 2021;58(5):298-303. https://doi.org/10.3928/01913913-20210319-01

Chaudhary N., Badhu B., & Deo P. Vernal keratoconjunctivitis among patients presenting to the outpatient department of ophthalmology of a tertiary care centre: a descriptive cross-sectional study. Journal of Nepal Medical Association 2023; 61(257):14-17. https://doi.org/10.31729/jnma.7933

Bruschi G., Ghiglioni D., Osnaghi S., Rosazza C., Marafon D., Landi M.et al. Role of ocular cytology in vernal keratoconjunctivitis. Immunity Inflammation and Disease 2019;8(1):3-7. https://doi.org/10.1002/iid3.278

Ghiglioni D., Martino P., Bruschi G., Vitali D., Osnaghi S., Corti M.et al. Stability and safety traits of novel cyclosporine A and tacrolimus ophthalmic galenic formulations involved in vernal keratoconjunctivitis treatment by a high-resolution mass spectrometry approach. Pharmaceutics 2020;12(4):378. https://doi.org/10.3390/pharmaceutics12040378

Erdem S.. Demographic and clinical features of vernal keratoconjunctivitis in a hot region: a hospital-based study. Van Medical Journal 2019;26(4):514-519. https://doi.org/10.5505/vtd.2019.24482

Bernales A., Berger O., & Hamada S.. Vernal keratoconjunctivitis: beyond the classic treatment. Journal of Pediatric Ophthalmology & Strabismus 2021;58(5). https://doi.org/10.3928/01913913-20210708-02

Kate A., Jain N., Jakati S., & Basu S.. Conjunctival autograft for tarsal keratinization in a case of chronic vernal keratoconjunctivitis. Cureus 2022. https://doi.org/10.7759/cureus.23089

Rasmussen M., Schou M., Bach‐Holm D., Heegaard S., Jørgensen C., Kessel L.et al.. Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta‐analyses. Acta Ophthalmologica 2021;100(1):35-44. https://doi.org/10.1111/aos.14858

Artesani M., Esposito M., Sacchetti M., Sansone A., Romanzo A., Buzzonetti L., et al Health‐related quality of life in children at the Diagnosis of vernal keratoconjunctivitis. Pediatric Allergy and Immunology 2021;32(6):1271-1277. https://doi.org/10.1111/pai.13520

Sacchetti M., Plateroti R., Bruscolini A., Giustolisi R., & Marenco M. Understanding vernal keratoconjunctivitis: beyond allergic mechanisms. Life 2021;11(10):1012. https://doi.org/10.3390/life11101012

Al-Okour K. and OdatT. Vernal keratoconjunctivitis clinical features and complications in 123 patients in the Gaza Strip. Journal of the Royal Medical Services 2014;21(1):55-62. https://doi.org/10.12816/0002580

Padmini S., Tasneem A., Nayak V., Rai T., Kumar S., & Indraja Y.. A comparative study of efficacy, tolerability, and safety of 0.03% tacrolimus eye ointment and 0.05% cyclosporin eye drops in the treatment of vernal keratoconjunctivitis. International Journal of Medical Ophthalmology 2021;3(1):23-32. https://doi.org/10.33545/26638266.2021.v3.i1a.58

Nche E., Okwen M., & Solomon A. Prevalence and clinical characteristics of vernal keratoconjunctivitis in sub-Saharan Africa. Current Opinion in Allergy and Clinical Immunology 2023;23(5):423-429. https://doi.org/10.1097/aci.0000000000000928

Ibraheim K. and Ahmed H. Vernal keratoconjunctivitis in Sudan and its impact on visual acuity. European Journal of Health Sciences 2024;10(3):44-63. https://doi.org/10.47672/ejhs.2025

Senthil S., Thakur M., Rao H., Mohamed A., Jonnadula G., Sangwan V.et al.. Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis. British Journal of Ophthalmology 2019;104(2):265-269. https://doi.org/10.1136/bjophthalmol-2019-313988

Vichyanond P., Pacharn P., Pleyer U., & Leonardi A. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes. Pediatric Allergy and Immunology 2014;25(4):314-322. https://doi.org/10.1111/pai.12197

Leonardi A., Righetti G., Giovannini G., Marchi V., & Occhiuto M. Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis. Current Opinion in Allergy and Clinical Immunology 2023;23(5):390-396. https://doi.org/10.1097/aci.0000000000000915

Cohen A., Goins K., Sutphin J., Wandling G., & Wagoner M. Penetrating keratoplasty versus deep anterior lamellar keratoplasty for the treatment of keratoconus. International Ophthalmology 2010;30(6):675-681. https://doi.org/10.1007/s10792-010-9393-9

Gupta S., Shah P., Grewal S., Chaurasia A., & Gupta V. Steroid-induced glaucoma and childhood blindness. British Journal of Ophthalmology 2015;99(11):1454-1456. https://doi.org/10.1136/bjophthalmol-2014-306557

Artesani M., Esposito M., Sacchetti M., Sansone A., Romanzo A., Buzzonetti L., et al Health‐related quality of life in children at the Diagnosis of vernal keratoconjunctivitis. Pediatric Allergy and Immunology 2021;32(6):1271-1277. https://doi.org/10.1111/pai.13520.

Downloads

Published

2025-06-30

How to Cite

Khan, A. A. ., & Ali, Z. . (2025). Visual Impairment in Patients with Vernal Keratoconjunctivitis. Biological and Clinical Sciences Research Journal, 6(6), 515–519. https://doi.org/10.54112/bcsrj.v6i6.2042

Issue

Section

Original Research Articles